To earn CME related to this news article, click here. February 25, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to warn of the risk for upper ...

March 31, 2005 — The U.S. Food and Drug Administration (FDA) has approved a once-monthly formulation of ibandronate sodium for the treatment and prevention of postmenopausal osteoporosis; entecavir ...

Aurobindo Pharma Ltd has submitted to BSE a copy of Press Release dated March 15, 2016 titled '' Aurobindo Pharma receives USFDA Approval for Ibandronate Sodium Tablets"Source : BSE Advisory Alert: It ...

Natco Pharma Ltd has launched Ibandronate Sodium in tablet and injection forms under the brand name of Bandrone. Ibandronate Sodium is used in the treatment of metastatic bone disease and elevated ...

Ibandronate (as sodium) 3mg/3mL; soln for IV inj. Ibandronate inhibits osteoclast activity and reduces bone resorption and turnover. In postmenopausal women, it reduces the elevated rate of bone ...

"The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Ibandronate Sodium Tablets, 150 mg," Aurobindo Pharma Limited said in a BSE filing. ...

Dr Reddy's Laboratories has confirmed that it has started marketing its anti-osteoporosis drug Ibandronate Sodium in the US. Indian drug maker Dr Reddy's Laboratories has confirmed that it has started ...

Dr Reddy's Laboratories announced today that it has launched Ibandronate sodium tablets (150 mg), a bioequivalent generic version of Boniva tablets, in the US market. Dr Reddy's Laboratories announced ...

Ibandronate (as sodium) 3mg/3mL; soln for IV inj. Ibandronate inhibits osteoclast activity and reduces bone resorption and turnover. In postmenopausal women, it reduces the elevated rate of bone ...

https://www.thehindubusinessline.com/companies/dr-reddys-launches-ibandronate-sodium-tablets-in-us/article20465777.ece Copy Pharma major Dr Reddy’s Laboratories Ltd ...